An NIH-funded team has developed a miniature device with the potential to predict the therapeutic option that will work best for a given tumor, changing the narratives for the approximately 25,000 people diagnosed with brain cancers in the U.S. each year.
When implanted into cancerous brain tissue during surgery, the rice-sized drug-releasing device can simultaneously conduct experiments to measure a tumor’s response to more than a dozen drugs or drug combinations.
More on this remarkable device is available on NIH.gov.
Need to know more about Medical Devices regulation changes? Get in touch with RegASK’s experts.
